Conversely, PHB2 inhibits cyclin-dependent kinase inhibitors (CKIs), such as p21 and p27, further enhancing cell cycle progression and reducing tumor cell susceptibility to DNA damage-induced apoptosis [40,41]. This evidence concerns the gene CDKN1A and neoplasm.